ACTIV-2: A Platform Trial for the Evaluation of Novel Therapeutics for the Treatment of Early COVID-19 in Outpatients

Clinical Trials Registration ClinicalTrials.gov Identifier: NCT04518410.

Automated summary

The clinical trial is registered with identifier NCT04518410.